Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 1/2 15Phase 2/3 5Phase 1 5Phase NA 2Phase 3 2

Status

Completed 132Unknown 48Recruiting 38Active not recruiting 28Terminated 18Not yet recruiting 15Withdrawn 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Motor Activity 1Leukemia 1Colonic Neoplasms 1

Interventions

Cisplatin 22Carboplatin 15Radiotherapy 13Paclitaxel 11Gemcitabine 10Rituximab 9Fluorouracil 9Drug Therapy 6Dexamethasone 5Cyclophosphamide 5Capecitabine 5Bevacizumab 5Vinorelbine 4Pemetrexed 4Nivolumab 4Methotrexate 4Etoposide 4Docetaxel 4Bendamustine Hydrochloride 4spartalizumab 3pertuzumab 3pembrolizumab 3fludarabine 3Vincristine 3Trastuzumab 3Surgical Procedures, Operative 3Standard of Care 3Prednisone 3Oxaliplatin 3Lenalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Withdrawn × Leucovorin × Clear all
NCT04488159 2024-09-20

iMAGINE

Medical University of Vienna

Phase 3 Withdrawn
Gastrointestinal

Colonic Neoplasms, Motor Activity

NCT00488605 2023-08-03

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

University of New Mexico

Phase 3 Withdrawn
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡